A Randomized, Multicenter, Phase 2 Trial of Camrelizumab With or Without Metastasis-directed Stereotactic Body Radiation Therapy in Recurrent or Metastatic Nasopharyngeal Carcinoma

• DOI: 10.1016/j.ijrobp.2024.10.019
• Publication Date: 2024-10-23T06:42:14Z
• Authors: Xin Zhang; Jin Yan; Qianqian Lei; Jialing Neo; Sze Huey Tan; Xiaolei Shu; Luo Huang; Bin Long; Yue Xie; Feng Wang; Yuwei Wang; Honglei Tu; Chengchen Wang; Lu Zhang; Jieying Yang; Jianwen Zhang; Huawen Liu; Darren W.T. Lim; Melvin L.K. Chua; Jiang Dong Sui; Ying Wang